Clinical Trial Update: Use of DNAse in Neutrophilic Asthma [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update notes the completion of Phase 1/2 testing of inhaled DNase for neutrophilic asthma, sponsored by National Jewish Health.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• DNase I (deoxyribonuclease I)

Snippet

Sponsor: National Jewish Health | Conditions: Neutrophilic Asthma | Phase 1, Phase 2 | Status: COMPLETED